UBS believes net profit can double for a2 Milk Co by FY30, underpinned by share gains in infant formula across both the English and Chinese label products. Margin expansion is also expected...

Commenting on the latest China’s Cross-Border E-Commerce (CBEC) price verification checks, Citi reckons growth in lower-priced, later-stage formulas may be driving a modest ...

Noting Chinese birth rates were 5.63 per thousand in 2025 versus 6.77 in 2024 and 6.39 in 2023, Morgan Stanley highlights the data infers the number of babies in 2025 fell -17% y/y despite government...

Morgans notes a2 Milk Co delivered a stronger-than-expected start to FY26, leading to upgraded sales and profit guidance. FY26 revenue growth of low double-digit is now expected compared to ...